BloombergLean L·
Dassault Systèmes to Buy Drug Trial Software Firm for $2 Billion
Dassault Systèmes SE will buy drug trial software maker ArisGlobal for as much as $2 billion as the French firm expands its push into life sciences.
Read at Bloomberg →